USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
US Hematology Diagnostics Market
US Hematology Diagnostics Market
Longer Product Cycles Stall Market Growth
RELEASE DATE
26-Jun-2014
26-Jun-2014
REGION
North America
North America
Research Code: NDE2-01-00-00-00
SKU: LS00044-NA-MR_16885
$4,950.00
In stock
SKU
LS00044-NA-MR_16885
Description
This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the data for which were collected through an end-user survey. The number of hematology analyzers installed by manufacturer and model were collected from a sample population of more than 4,000 sites. The sample population included hospitals, reference laboratories, and physician’s office laboratories.
Table of Contents
Key Findings
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
Market Engineering Measurements (continued)
CEO’s Perspective
Key Companies to Watch
Executive Summary—2 Big Predictions
Market Segmentation
Market Segmentation (continued)
Customer Segmentation and Landscape
Most Commonly Ordered Hematology Tests
Defining Healthcare Trends in the Future
New Market Opportunities
New Market Opportunities (continued)
New Market Opportunities (continued)
Merger, Acquisition, and Partnership Assessment
Merger, Acquisition, and Partnership Assessment (continued)
Market Drivers
Market Restraints
Market Engineering Measurements
Forecast Assumptions and Definitions
Revenue Forecast
Revenue Forecast Discussion
Procurement Process
PEST Analysis
Competitive Structure
Market Share
Market Share Analysis
Market Share Analysis (continued)
Market Share Analysis (continued)
Sysmex—Company Dashboard
Beckman Coulter (Danaher)—Company Dashboard
Abbott Diagnostics—Company Dashboard
Horiba ABX—Company Dashboard
Siemens Healthcare Diagnostics—Company Dashboard
Popularity Trend by Model Type
Popularity Trend by Model Type (continued)
Popularity Trend by Model Type (continued)
Popularity Trend by Model Type (continued)
Popularity Trend by Model Type (continued)
Popular Models—Pricing Analysis
Popular Models—Pricing Analysis (continued)
Revenue Forecast
Revenue Forecast Discussion
Installed Base and Pricing Analysis
Revenue Forecast
Revenue Forecast Discussion
The Last Word—2 Big Predictions
The Last Word—Discussion
The Last Word—Discussion (continued)
Legal Disclaimer
Market Definitions
Market Definitions (continued)
Market Background
Market Background (continued)
Market Background (continued)
Market Background (continued)
Hematology Tests and CPT Codes
Drivers Explained
Drivers Explained (continued)
Drivers Explained (continued)
Restraints Explained
Restraints Explained (continued)
Market Engineering Methodology
Associated Market Research Services
Learn More—Next Steps
This research service analyzes and provides forecasts of the US hematology diagnostics market from 2012 to 2017. The market is broadly classified into 2 major segments: analyzers and reagents. The US hematology market was sized using a bottom-up revenue model developed from the actual installed base of hematology analyzers in US laboratories, the data for which were collected through an end-user survey. The number of hematology analyzers installed by manufacturer and model were collected from a sample population of more than 4,000 sites. The sample population included hospitals, reference laboratories, and physicians office laboratories.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Divyaa Ravishankar |
| WIP Number | NDE2-01-00-00-00 |
| Is Prebook | No |